It is a pharma foreign private limited company based in Hyderabad, Telangana, India, established in 2021.
2021 | Hyderabad, Telangana, India | ActiveGlycos Biomedical Private Limited, a active foreign private limited company, was established on 03 September 2021 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230TG2021FTC154601. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pervinder Singh Bhogal (Director), Santosh Kumar Manupati (Director), Ounali Sherali Jaffer (Director). It is based at H No-5-11/112/212 Senthan Green Park Near Teachers Colony, Hyderabad, Telangana, 502032.
U24230TG2021FTC154601
154601
03 September 2021
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Glycos Biomedical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pervinder Singh Bhogal | Director | 03 Sep 2021 | Current |
| Santosh Kumar Manupati | Director | 03 Sep 2021 | Current |
| Ounali Sherali Jaffer | Director | 03 Sep 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Glycos Biomedical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Glycos Biomedical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Glycos Biomedical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glycos Biomedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glycos Biomedical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pervinder Singh Bhogal was appointed as a Director was appointed as a Director on 03 Sep 2021 & has been associated with this company since 4 years 3 months . was completed.
Progress on Santosh Kumar Manupati was appointed as a Director was appointed as a Director on 03 Sep 2021 & has been associated with this company since 4 years 3 months . was documented.
Progress on Ounali Sherali Jaffer was appointed as a Director was appointed as a Director on 03 Sep 2021 & has been associated with this company since 4 years 3 months . was documented.
The activity Glycos Biomedical Private Limited was registered on 03 Sep 2021 with Roc Hyderabad & aged 4 years 3 months as per MCA records. was completed.
The CIN of Glycos Biomedical Private Limited is U24230TG2021FTC154601.
Glycos Biomedical Private Limited is headquartered at H No-5-11/112/212 Senthan Green Park Near Teachers Colony, Hyderabad, Telangana, 502032.
Glycos Biomedical Private Limited was incorporated on 03 September 2021.
The current directors of Glycos Biomedical Private Limited are
The primary industry of Glycos Biomedical Private Limited is Pharma.
Glycos Biomedical Private Limited is unlisted.
The authorized capital of Glycos Biomedical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX